Inflammation:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Inflammation Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Inflammation 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Inflammation 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Inflammation Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novo Nordisk A/S 35
Clinical Trial Overview of Novo Nordisk A/S 35
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Bausch & Lomb Incorporated 38
Clinical Trial Overview of Bausch & Lomb Incorporated 38
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Sirion Therapeutics, Inc. 41
Clinical Trial Overview of Sirion Therapeutics, Inc. 41
Allergan, Inc. 42
Clinical Trial Overview of Allergan, Inc. 42
Perrigo Company 43
Clinical Trial Overview of Perrigo Company 43
Sandoz Inc. 44
Clinical Trial Overview of Sandoz Inc. 44
Galapagos NV 45
Clinical Trial Overview of Galapagos NV 45
Infinity Pharmaceuticals, Inc. 46
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 46
Amgen Inc. 47
Clinical Trial Overview of Amgen Inc. 47
Celgene Corporation 48
Clinical Trial Overview of Celgene Corporation 48
SIFI S.p.A 49
Clinical Trial Overview of SIFI S.p.A 49
X-pert Med GmbH 50
Clinical Trial Overview of X-pert Med GmbH 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Merck & Co., Inc. 52
Clinical Trial Overview of Merck & Co., Inc. 52
Takeda Pharmaceutical Company Limited 53
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 53
Clinical Trial Overview of Top Institutes / Government 54
National Heart, Lung, and Blood Institute 54
Clinical Trial Overview of National Heart, Lung, and Blood Institute 54
Radboud University 56
Clinical Trial Overview of Radboud University 56
Vanderbilt University 57
Clinical Trial Overview of Vanderbilt University 57
Maastricht University Medical Center 58
Clinical Trial Overview of Maastricht University Medical Center 58
University of Cincinnati 59
Clinical Trial Overview of University of Cincinnati 59
Emory University 60
Clinical Trial Overview of Emory University 60
The National Institute of Allergy and Infectious Diseases 61
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 61
University of California, Davis 62
Clinical Trial Overview of University of California, Davis 62
Assistance Publique – Hopitaux de Paris 63
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 63
University of California, San Francisco 64
Clinical Trial Overview of University of California, San Francisco 64
U.S. Department of Veterans Affairs 65
Clinical Trial Overview of U.S. Department of Veterans Affairs 65
Massachusetts General Hospital 66
Clinical Trial Overview of Massachusetts General Hospital 66
Stanford University 67
Clinical Trial Overview of Stanford University 67
Leiden University Medical Center 68
Clinical Trial Overview of Leiden University Medical Center 68
The Ohio State University 69
Clinical Trial Overview of The Ohio State University 69
Medical University of Vienna 70
Clinical Trial Overview of Medical University of Vienna 70
Assaf-Harofeh Medical Center 71
Clinical Trial Overview of Assaf-Harofeh Medical Center 71
The University of Edinburgh 72
Clinical Trial Overview of The University of Edinburgh 72
Aarhus University 73
Clinical Trial Overview of Aarhus University 73
Brigham and Women’s Hospital 74
Clinical Trial Overview of Brigham and Women’s Hospital 74
Five Key Clinical profiles 75
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 109


【レポート販売概要】

■ タイトル:Inflammation:グローバル臨床試験レビューH2, 2013
■ 英文:Inflammation Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162194
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。